About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us

  

 

  BVA-100: Product Highlights

 
 Features
 

View the BVA-100 slide presentation >
(Adobe Flash)

  

  
    

Featured video

BVA-100 featured at KENS5 in San Antonio with Dr. Robert Schnitzler of the Heart Hospital of South Texas at Methodist Hospital (19-MB mpeg) >

 
   
   
   
   
 

< Return to Product Literature

  • The BVA-100 calculates true normal blood volume for a specific individual.

  • The BVA-100 directly measures circulating blood volume in 90 minutes or less.

  • Individuals of different body sizes may have identical hematocrits but vastly different blood volumes.

  • Accurate knowledge of blood volume can prevent serious complications from undertransfusion caused by unrecognized severe hypovolemia.

  • The BVA-100 is the first instrument for the measurement of human blood volume to receive patents in the U.S., European Common Market, and Japan.

  • The BVA-100 helps differentiate the post-surgical normovolemic anemic patient from the anemic hypovolemic patient.

  • The BVA-100 can accurately ascertain individual patient's presurgical blood volume status to enable more precise fluid replacement during and after surgery.

  • The BVA-100 provides objective data upon which physicians can base decisions to transfuse, reducing unnecessary use of blood products and physician liability.

  • The BVA-100 reduces morbidity from potentially contaminated blood by avoiding unnecessary transfusions.

  • The BVA-100 is useful in measuring blood volume in conditions complicated by fluid retention such as hepatic and renal disease.

 

Menu Options

DAXOR Home Page

Overview

How it Works

How it Compares

Product Literature

Site Requirements

GSA Price List

Revenue and Cost Analysis

Indications

Clinical Evidence

Case Studies

FAQs

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

 


© 2010 DAXOR Corporation. All Rights Reserved.